3 Earnings Winners Holding Strong in a Range-Bound Market
Other
During Q4 2025 earnings season, Johnson & Johnson, Taiwan Semiconductor Manufacturing, and Meta have delivered results above market expectations and continue to show growth potential. JNJ benefits from drug price agreements with exemptions, TSM expects 30% revenue growth with strong AI investments, and Meta raised Q1 2026 guidance significantly above consensus while planning record capital spending on AI infrastructure. All three stocks remain in upward trends despite the broader market moving i...
Continue Reading